AbCellera Biologics Inc (ABCL)
3.76
+0.13
(+3.58%)
USD |
NASDAQ |
Apr 26, 16:00
3.70
-0.06
(-1.60%)
After-Hours: 20:00
AbCellera Biologics Market Cap: 1.101B for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.063B |
| April 24, 2024 | 1.142B |
| April 23, 2024 | 1.162B |
| April 22, 2024 | 1.174B |
| April 19, 2024 | 1.133B |
| April 18, 2024 | 1.145B |
| April 17, 2024 | 1.148B |
| April 16, 2024 | 1.186B |
| April 15, 2024 | 1.224B |
| April 12, 2024 | 1.271B |
| April 11, 2024 | 1.282B |
| April 10, 2024 | 1.306B |
| April 09, 2024 | 1.385B |
| April 08, 2024 | 1.315B |
| April 05, 2024 | 1.271B |
| April 04, 2024 | 1.288B |
| April 03, 2024 | 1.282B |
| April 02, 2024 | 1.265B |
| April 01, 2024 | 1.300B |
| March 28, 2024 | 1.326B |
| March 27, 2024 | 1.315B |
| March 26, 2024 | 1.256B |
| March 25, 2024 | 1.341B |
| March 22, 2024 | 1.344B |
| March 21, 2024 | 1.379B |
| Date | Value |
|---|---|
| March 20, 2024 | 1.385B |
| March 19, 2024 | 1.347B |
| March 18, 2024 | 1.344B |
| March 15, 2024 | 1.379B |
| March 14, 2024 | 1.376B |
| March 13, 2024 | 1.438B |
| March 12, 2024 | 1.429B |
| March 11, 2024 | 1.452B |
| March 08, 2024 | 1.397B |
| March 07, 2024 | 1.438B |
| March 06, 2024 | 1.426B |
| March 05, 2024 | 1.408B |
| March 04, 2024 | 1.464B |
| March 01, 2024 | 1.479B |
| February 29, 2024 | 1.479B |
| February 28, 2024 | 1.487B |
| February 27, 2024 | 1.499B |
| February 26, 2024 | 1.449B |
| February 23, 2024 | 1.426B |
| February 22, 2024 | 1.420B |
| February 21, 2024 | 1.408B |
| February 20, 2024 | 1.555B |
| February 16, 2024 | 1.563B |
| February 15, 2024 | 1.546B |
| February 14, 2024 | 1.518B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.063B
Minimum
Apr 25 2024
15.64B
Maximum
Dec 11 2020
3.778B
Average
2.853B
Median
Market Cap Benchmarks
| Acasti Pharma Inc | 27.45M |
| Aurinia Pharmaceuticals Inc | 709.35M |
| Edesa Biotech Inc | 14.17M |
| Lexaria Bioscience Corp | 30.28M |
| InMed Pharmaceuticals Inc | 1.394M |
Market Cap Related Metrics
| PS Ratio | 28.59 |
| Price to Book Value | 0.9553 |
| Price | 3.76 |
| Earnings Yield | -13.83% |